Stitch Fix stock falls on weaker-than-expected sales outlook, executive shake-up

Shares of Stitch Fix Inc. fell after hours after the online clothing-selection and styling service offered up a weaker-than-expected sales forecast.

Shares of Stitch Fix Inc. fell after hours on Tuesday after the online clothing-selection and styling service offered up a weaker-than-expected sales forecast.

And in the latest executive shake-up for the company, Stitch Fix SFIX said that Dan Jedda would step down as chief financial officer “to pursue another opportunity.” He will be replaced by David Aufderhaar, current senior vice president of finance, on April 3. Analysts polled by FactSet expected Stitch Fix to report a per-share loss of 34 cents, on revenue of $413 million. They expected active clients of 3.6 million.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

MarketWatch /  🏆 3. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

USD/CNY fix: 6.8951 from the previous fix of 6.9117In recent trade today, the People’s Bank of China (PBOC) set the yuan at 6.8951 from the previous fix of 6.9117 and the prior close of 6.9015. About t
Read more »

USD/CNY fix: 6.9156 vs. prev fix 6.8951In recent trade today, the People’s Bank of China (PBOC) set the yuan at 6.9156 vs. previous fix of 6.8951 and prior close of 6.9335). About the fix C
Read more »

Delta’s stock has significantly trailed its big rivals. That could change, analysts say.Shares of Delta Air Lines Inc. moved higher on Tuesday after Evercore analysts upgraded the stock.
Read more »

MO Stock Price | Altria Group Inc. Stock Quote (U.S.: NYSE) | MarketWatchMO | Complete Altria Group Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Read more »

BioMarin’s stock falls after another company’s dwarfism drug moves into Phase 3 clinical trialsShares of BioMarin Pharmaceutical Inc. were down about 6.0% in premarket trading on Monday after BridgeBio Pharma Inc. shared positive Phase 2 clinical data...
Read more »

Murder, Inc.: Gang of Crows Runs Denver's Uptown NeighborhoodTens of thousands of the black birds have made themselves at home in North Capitol Hill.
Read more »